logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sivacharan Kollipara

dr. reddy's laboratories ltd.
H指数:18
被引数:939

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a novel rabeprazole modified release formulation to reduce the dosing frequency: A trial and triumph with physiologically based biopharmaceutics modeling

开发一种新型雷贝拉唑缓释制剂以减少给药频率：基于生理学的生物药剂学建模的尝试与成功

Journal of Pharmacokinetics and Pharmacodynamics
IF2.8
2026-05-160
PRE
Maddukuri, Harika; Boddu, Rajkumar; Chaudhari, Sangmesh Mallikarjun; Choudhury, Anup Avijit; Kambam, Veena; Khan, Sohel Mohammed; Naidu, Venkat Ramana; Singh, Sanjay Kumar; Saini, Anuj Kumar; Kollipara, Sivacharan
Exploring Additional Strength Biowaiver Perspectives in the ICH M13B Framework for Immediate Release Solid Oral Dosage Forms: Opportunities & Challenges (Nov, 10.1007/s43441-025-00900-0, 2025)

在ICH M13B框架下对即释固体制剂探索额外规格生物豁免的观点：机遇与挑战

Therapeutic Innovation & Regulatory Science
IF1.9
2026-01-010
PRE
Boddu, Rajkumar; Rachapally, Arvind; Khan, Mohammed Shareef; Khan, Sohel Mohammed; Martins, Frederico S.; Saini, Anuj Kumar; Kollipara, Sivacharan
Leveraging Model Integrated Bioequivalence (MIBE) to Address Regulatory Concerns and Waive Repeat Bioequivalence Studies-A Case Study with Clopidogrel

利用模型集成生物等效性（MIBE）解决监管关切并豁免重复生物等效性研究——一项关于氯吡格雷的案例研究

Journal of Clinical Pharmacology
IF2.3
2025-12-170
PRE
Gopalakrishnan, Mathangi; Bhattiprolu, Adithya Karthik; Gobburu, Joga; Boddu, Rajkumar; Kambam, Veena; Khan, Sohel Mohammed; Saini, Anuj Kumar; Kollipara, Sivacharan
Emerging perspectives on leveraging physiologically based biopharmaceutics modeling (PBBM) for BCS class III biowaivers: a webinar summary

新兴观点：利用生理学基础的生物药剂学建模（PBBM）实现BCS第III类生物豁免：网络研讨会总结

Journal of Pharmaceutical Sciences
IF3.8
2025-10-200
OAAI
Lanyan (Lucy) Fang; Shereeni Veerasingham; Yunming Xu; Alfredo Garcia-Arieta; Sivacharan Kollipara; Yuvaneshwari Kanagasabapathy; Tausif Ahmed; Frederico Severino Martins; Sandra Suarez-Sharp
Correction: Nitrosamines Risk Assessment for Biopharmaceutics Classifcation System Class IV Molecule Containing Immediate Release Products: Use of In-Silico Prediction Tools and Physiologically Based Pharmacokinetic Modeling

更正：用于立即释放产品的生物药剂学分类系统IV类分子中硝基亚硝胺风险评估：应用计算机预测工具和生理基础药代动力学模型

aaps journal
IF0
2025-06-040
PRE
Sivacharan Kollipara; Mahendra Chougule; Karthik Parsa; Priyansh Pandya; Tausif Ahmed
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory Submissions

基于生理学的生物药剂学模型报告模板开发：从监管提交角度考虑的质量改进

MOLECULAR PHARMACEUTICS
IF4.5
2025-04-290
OA
Arora, Sumit; Pepin, Xavier; Jamei, Masoud; Sharma, Pradeep; Heimbach, Tycho; Wagner, Christian; Bransford, Philip; Kollipara, Sivacharan; Ahmed, Tausif; Hingle, Martin; Scherholz, Megerle; Stamatis, Stephen D.; Cano-Vega, Mario; Mistry, Nena; Tannergren, Christer; Borges, Luiza; Lindahl, Anders; Rullo, Gregory; Mackie, Claire; Mitra, Amitava; Kushner, Joseph; Harish Jain, Krutika Meena; Polli, James E.

研究方向

暂未获取到该数据
T
Tausif Ahmed
H 指数:19论文数:78被引数:1,473
R
Rajkumar Boddu
H 指数:8论文数:41被引数:225
A
Anuj Kumar Saini
H 指数:2论文数:17被引数:106
T
Tycho Heimbach
H 指数:36论文数:98被引数:5,146
F
Frederico Severino Martins
H 指数:16论文数:60被引数:700
A
Adithya Karthik Bhattiprolu
H 指数:7论文数:11被引数:145
S
Sohel Mohammed Khan
H 指数:2论文数:13被引数:17
M
Mahendra Chougule
H 指数:4论文数:8被引数:45
S
Siddharth Chachad
H 指数:9论文数:12被引数:230
H 指数:0论文数:27被引数:210